Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The European IP Helpdesk, together with the European Innovation Council and SMEs Executive Agency, organise a webinar on maximising the impact of horizon project results.
Learn more about exploitation of Intellectual Property (IP) rights in Horizon projects. This webinar gives an overall view of the creation and the development of IP rights both during and after the duration of an Horizon project. The most common planning mistakes will be analysed and some practical tips will be given.
After the training, participants should have a better understanding of the following:
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space AI, data & cloud Cybersecurity Defence
Security Cybersecurity Defence EDF NATO-EDA
Digital, Industry & Space AI, data & cloud
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.